| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |